Boehringer Ingelheim and Atlanta Braves Foundation Partner to Support Shelter Dogs in Need
DULUTH, Ga., April 26, 2024 /PRNewswire/ -- Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to announce a collaborative effort to support shelter adoptions across Braves Country.
- DULUTH, Ga., April 26, 2024 /PRNewswire/ -- Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to announce a collaborative effort to support shelter adoptions across Braves Country.
- On August 21, there will be a special on-field check presentation to the Ozzie Albies Foundation during the Braves home game against the Philadelphia Phillies to support shelter animals.
- "We are incredibly excited to be part of this pet-centric initiative," said Daniel Watkins, Head of U.S. Pet at Boehringer Ingelheim.
- In addition to providing much-needed resources, Boehringer Ingelheim is also working to raise awareness about the importance of adopting shelter animals.